At a glance
Our CEO Ciara Doran attended the Cambridge Angels networking event, engaging with investors and founders to discuss Sansanima’s plan to replace animal testing in the manufacture of critical medicines and vaccine products.
Event highlights
The event brought together portfolio companies and invited guests across therapeutics, diagnostics, platform biotech, and AI enabled drug discovery. Conversations focused on scaling science, regulatory readiness, and industry partnerships.
Why it matters
Engagements like this help accelerate partnerships for pilots, method transfer, and scale up. They also support our aim to move industry towards specific, sensitive, and reproducible cell based testing that is animal free and ready for regulated environments.
Thank You
Thank you to Cambridge Angels for the invitation and a highly valuable event.